The Recall Desk
SevereFDA (Drugs)·D-1011-2020·Announced 2020-03-18

Redline Pharmacy Recalls Morphine Sulfate Due to Processing Controls

Redline Pharmacy Solutions is recalling Morphine Sulfate (MITIGO) 5 mg/mL intrathecal syringes due to a lack of processing controls.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score according to the rubric.

Plain-English summary

Redline Pharmacy Solutions is recalling Morphine Sulfate (MITIGO), 5 mg/mL intrathecal, 40 mL per syringe. The recall is being conducted due to a lack of processing controls.

The affected product is identified by Lot 02242020@14. The product was sold to patients in Nebraska.

Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for instructions on how to return or dispose of the medication.

The recalled product

Product
Morphine Sulfate (MITIGO), 5 mg/mL intrathecal, 40 mL per syringe. Redline Specialty Pharmacy, 2415 Osborne Drive E, #100 Hastings, NE 68901
Manufacturer
Redline Pharmacy Solutions
Category
Drug — Intrathecal Medication
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot 02242020@14

Distribution

Distributed in 1 state:

Part of a larger recall action

This product is one of 6 recalled by Redline Pharmacy Solutions under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 6 products in this recall →

Related recalls

Same manufacturer · Redline Pharmacy Solutions

See all →

Same hazard · processing controls

See all →